middle.news

Paradigm’s regional data keeps a narrow path open after Phase 3 setback

11:12am on Friday 30th of October, 2026 AEDT • Biotechnology and Pharmaceuticals
Read Story

Paradigm’s regional data keeps a narrow path open after Phase 3 setback

11:12am on Friday 30th of October, 2026 AEDT
Key Points
  • Phase 3 PARA_OA_012 met its pre-specified futility criterion
  • A$13.45 million net operating cash outflow during the quarter
  • A$4.33 million cash balance at 30 September
  • Securities remain suspended during voluntary administration
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Paradigm Biopharmaceuticals (ASX:PAR)
OPEN ARTICLE